Post by icemandios on Jan 31, 2018 14:06:27 GMT
TransEnterix to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
RESEARCH TRIANGLE PARK, N.C.
TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the LEERINK Partners 7th Annual Global Healthcare Conference at The Lotte New York Palace Hotel in New York, New York. The presentation is scheduled to take place at 1:30 PM Eastern, February 14, 2018.
A live audio webcast of the conference presentation will be available online at the investor relations page of the Company’s website at ir.transenterix.com/events.cfm. A replay of the webcast will be archived on the website for approximately 90 days.
About TransEnterix
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options in today's value-based healthcare environment. The company is focused on the commercialization of the Senhance™ Surgical Robotic System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera control. The Senhance Surgical Robotic System is available for sale in the US, the EU and select other countries. For more information, visit the TransEnterix website at www.transenterix.com.
RESEARCH TRIANGLE PARK, N.C.
TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the LEERINK Partners 7th Annual Global Healthcare Conference at The Lotte New York Palace Hotel in New York, New York. The presentation is scheduled to take place at 1:30 PM Eastern, February 14, 2018.
A live audio webcast of the conference presentation will be available online at the investor relations page of the Company’s website at ir.transenterix.com/events.cfm. A replay of the webcast will be archived on the website for approximately 90 days.
About TransEnterix
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options in today's value-based healthcare environment. The company is focused on the commercialization of the Senhance™ Surgical Robotic System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera control. The Senhance Surgical Robotic System is available for sale in the US, the EU and select other countries. For more information, visit the TransEnterix website at www.transenterix.com.